Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Mayo Clinic proceedings - 1 Feb 2010

Tefferi Ayalew, Gotlib Jason, Pardanani Animesh

Abstract excerpt

Acquired eosinophilia is operationally categorized into secondary, clonal, and idiopathic types. Causes of secondary eosinophilia include parasite infections, allergic or vasculitis conditions, drugs, and lymphoma. Clonal eosinophilia is distinguished from idiopathic eosinophilia by the presence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neoplasm
Share to Decision Trees
Share to Eosinophilia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypereosinophilic Syndrome

Share to Leukemia, Myelomonocytic, Chronic

Share to Mastocytosis

Share to mRNA Cleavage and Polyadenylation Factors

Share to Receptors, Platelet-Derived Growth Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 20053713
DOI: 10.4065/mcp.2009.0503
PMCID: PMC2813824

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20053713-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.PMID 20053713Read ↗

World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.Semantic proximity Read ↗

Hypereosinophilic syndrome.Semantic proximity Read ↗

The Diagnostic Work-Up of Hypereosinophilia.Semantic proximity Read ↗

Management of F/P+/- hypereosinophilic syndromes: case report and treatment review.Semantic proximity Read ↗

Hematological Neoplasm with EosinophiliaSemantic proximity Read ↗

Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia.Semantic proximity Read ↗

The international consensus classification of eosinophilic disorders and systemic mastocytosisSemantic proximity Read ↗

Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapySemantic proximity Read ↗

Molecular Classification and Pathogenesis of Eosinophilic Disorders: 2005 UpdateSemantic proximity Read ↗

The hypereosinophilic syndromes: current concepts and treatments.Semantic proximity Read ↗

Updates on eosinophilic disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.